1. Greene FL, Page DL, Fleming ID, et al (American Joint Committee on Cancer), eds. Prostate. In: AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002; 309-313.
2. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation. Eur J Cancer. 1996; 32:2474-2484.
3. Wikstrom P, Lissbrant IF, Stattin P, et al. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Prostate. 2002; 51:268-275.
4. de la Taille A, Katz AE, Bagiella E, et al. Microvessel density as a predictor of PSA recurrence after radical prostatectomy: a comparison of CD34 and CD31. Am J Clin Pathol. 2000; 113:555-562.
5. Giatromanolaki A, Sivridis E, Koukourakis MI, et al. Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinoma? Oncol Res. 1999; 11:205-212.